SMTL ID : 3nxq.2 (1 other biounit)

Angiotensin Converting Enzyme N domain glycsoylation mutant (Ndom389) in complex with RXP407

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.1: 4 residues within 4Å: Chain A: T.478, N.480, T.482, H.483 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.478, A:T.478, A:N.480, A:T.482, A:T.482

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 5 residues within 4Å: Chain A: N.45, T.47, E.49, N.50, R.326 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG-NAG-BMA-FUC.3: 8 residues within 4Å: Chain A: N.416, D.417, T.418, D.421, E.522, G.523, P.524, Q.527 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.418

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 6 residues within 4Å: Chain A: W.201, Y.202, P.385, P.497, I.499, R.500 Ligand excluded by PLIP

1 x ZN: ZINC ION(Non-covalent)

ZN.5: 4 residues within 4Å: Chain A: H.361, H.365, E.389 Ligands: RX4.6 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.361, A:H.365, A:E.389

1 x RX4: N~2~-acetyl-N-{(1R)-1-[(S)-[(2S)-3-{[(2S)-1-amino-1-oxopropan-2-yl]amino}-2-methyl-3-oxopropyl](hydroxy)phosphoryl]-2-phenylethyl}-L-alpha-asparagine(Non-covalent)

RX4.6: 20 residues within 4Å: Chain A: Q.259, H.331, A.332, S.333, A.334, H.361, E.362, H.365, Y.369, R.381, H.388, E.389, F.435, K.489, F.490, H.491, T.496, Y.498, Y.501 Ligands: ZN.5 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:F.435, A:F.490, A:F.490, A:T.496, A:Y.501 Hydrogen bonds: A:Q.259, A:A.334, A:A.334, A:Y.369, A:K.489, A:K.489 Water bridges: A:R.381, A:E.389, A:E.389, A:R.500, A:R.500, A:Y.501 Salt bridges: A:H.365, A:R.381, A:H.388

2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.7: 4 residues within 4Å: Chain A: R.453, D.462, Y.465, L.466 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.453 Water bridges: A:Q.444, A:T.454 PG4.8: 5 residues within 4Å: Chain A: Q.286, G.287, W.288, H.292 Ligands: P6G.9 No protein-ligand interaction detected (PLIP)

1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)

P6G.9: 5 residues within 4Å: Chain A: R.295, V.296, E.299, I.408 Ligands: PG4.8 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:I.408

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.10: 4 residues within 4Å: Chain A: R.96, D.189, G.190, F.191 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Anthony, C.S. et al., The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407. J.Biol.Chem. (2010)

Release Date

2010-09-08

Peptides

Angiotensin-converting enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Angiotensin-converting enzyme

Related Entries With Identical Sequence